CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chinook Therapeutics Inc Company Snapshot
Chinook Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chinook Therapeutics Inc with three other companies in this sector in UNITED STATES : Spero Therapeutics Inc (2019 sales of $18.15 million of which 100% was Pharmaceutical), Kalvista Pharmaceuticals Inc ($16.13 million of which 100% was Pharmaceuticals), and Mesoblast Ltd ($16.72 million of which 100% was Mesenchymal Precursor Cell).

Sales Analysis. During the year ended December of 2019, sales at Chinook Therapeutics Inc were $17.26 million. This is an increase of 14.4% versus 2018, when the company's sales were $15.09 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chinook Therapeutics Inc
  Stock Performance Chart for Chinook Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 16.73
(Figures in U.S. Dollars)
1 Week 2.4%   13 Weeks 21.2%  
4 Weeks 17.4%   52 Weeks 231.3%  
 
Chinook Therapeutics Inc Key Data:
  Ticker: KDNY Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 17,258,000
(Year Ending Jan 2020).
Employees: 96
  Currency: U.S. Dollars Market Cap: 271,223,431
  Fiscal Yr Ends: December Shares Outstanding: 16,211,801
  Share Type: Common Closely Held Shares: 4,832,557
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.